SILK Insider Trading Activity and SEC Form 4 Filings
SILK insider trading summary
No open-market insider purchases or sales of Silk Road Medical Inc (SILK) have been reported on SEC Form 4 in the past 12 months.
Latest SILK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 19, 2024 | Kevin M Klemz | EVP/Chief Legal Officer/Sec. | Sell | $61K (2,268 @ $27.10) |
| Jul 3, 2024 | Andrew S. Davis | Chief Commercial Officer | Sell | $2K (66 @ $27.00) |
| Mar 5, 2024 | Andrew S. Davis | Chief Commercial Officer | Sell | $94K (5,481 @ $17.17) |
| Mar 5, 2024 | Marie L. Jones | VP, Finance and CAO | Sell | $45K (2,602 @ $17.17) |
| Mar 5, 2024 | Kevin M Klemz | EVP/Chief Legal Officer/Sec. | Sell | $43K (2,497 @ $17.17) |
| Mar 5, 2024 | Kevin J. Ballinger | Insider | Buy | $199K (11,700 @ $16.99) |
| Mar 5, 2024 | Lucas W. Buchanan | COO/CFO | Sell | $170K (9,877 @ $17.17) |
| Mar 5, 2024 | Richard Ruedy | EVPClin&Reg.Affairs&QA | Sell | $65K (3,800 @ $17.17) |
| Feb 29, 2024 | Richard Ruedy | EVPClin&Reg.Affairs&QA | Sell | $67K (3,000 @ $22.25) |
| Oct 27, 2023 | Marie L. Jones | CAO and VP, Finance | Sell | $4K (656 @ $6.61) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.